Children Exposed to But Uninfected With HIV Are Smaller at Birth
Children exposed to but uninfected with HIV were smaller and shorter at birth compared with children unexposed to HIV.
Women’s Health
Dolutegravir-Based ART and Pregnancy Outcomes
Two studies investigating the safety of dolutegravir-based ART during pregnancy found that higher rates of adverse pregnancy outcomes did not occur in women who initiated treatment before conception.
Rates of Anal Cancer Precursors High in Women Living With HIV
The prevalence of anal high-grade squamous intraepithelial lesions, which precede anal cancer, is high among women living with HIV in the US.
USPSTF Reaffirms Recommendation for HBV Screening During Pregnancy
The United States Preventative Service Task Force has issued a statement that reaffirms its 2009 recommendations for screening pregnant women for hepatitis B virus.
No Substantial Difference in HIV Risk Using Injectable, Intrauterine, or Implantable Contraceptives
When comparing hormonal contraceptive methods, particularly IM depot medroxyprogesterone acetate with an IUD and a levonorgestrel implant, there was no substantial difference in HIV risk among African women.
Guidance Updated for Managing Infants at Risk for Group B Strep
New guidelines for the management and treatment of group B streptococcal disease in infants published.
Trichomonas vaginalis Prevalence in the United States, 2013-2016
Among noninstitutionalized adolescents and adults in the United States between 2013 and 2016, 1.3% tested positive for Trichomonas vaginalis infection.
HIV/HPV Coinfection Is More Common in Younger Nepalese Women
Understanding the pattern and prevalence of HPV coinfection in women with HIV may provide insight into future vaccination programs and help establish routine cervical cancer screening protocols.
Novel HIV-1 Inhibitor Shows Promise for Future Treatment of HIV in Women
Avirulins may provide a valuable chemical foundation for the development of the next generation of prophylactic medications for HIV-1 in women, according to results of a study presented at American Society of Microbiology (ASM) Microbe 2019 held from June 20-24, 2019, in San Francisco, California. Although much progress has been made in decreasing the risk…
Breastmilk GBS Capsular Antibody Levels: Lower Risk for Late Onset Disease?
The breastmilk secretory IgA (sIgA) capsular antibody was associated with lower risks for late-onset disease from group B streptococcal (GBS) invasive disease, according to study data published in Clinical Infectious Diseases. Using a matched case-control study in infants <3months of age in Johannesburg, South Africa, investigators collected breastmilk samples from case and control participants, matched…
Next post in Prevention
